Skip to main content
Dharamvir Jain, MD, Oncology, Houston, TX, Houston Methodist Hospital

DharamvirJainMDFACP

Oncology Houston, TX

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Thoracic Cancer

Previously Associate Professor of Medicine, Division of Hematology and Medical Oncology, University of Louisville School of Medicine

Dr. Jain is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Jain's full profile

Already have an account?

Summary

  • Medical oncologist with active clinical interest in breast cancer clinical care, developmental therapeutics and clinical trials

Education & Training

  • Westchester Medical Center
    Westchester Medical CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
  • BronxCare Health System
    BronxCare Health SystemResidency, Internal Medicine, 1997 - 2000
  • Maulana Azad Medical College
    Maulana Azad Medical CollegeClass of 1990

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2020 - 2025
  • KY State Medical License
    KY State Medical License 2003 - 2025
  • IN State Medical License
    IN State Medical License 2019 - 2025
  • OH State Medical License
    OH State Medical License 2019 - 2024
  • NJ State Medical License
    NJ State Medical License 2001 - 2003
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Fellow of American College of Physicians
  • Regional Top Doctor Castle Connolly, 2014
  • Fellow American College of Physicians, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Management of Immunotherapy Toxicities in Older Adults  
    Bhandari S, Gill AS, Perez CA, Jain D, Semin Onc., 1/1/2018
  • DNA repair signature is associated with anthracycline response in triple negative breast cancer patients  
    Rodriguez AA, Makris A, Wu MF, Rimawi M, Froehlich A, Dave B, Hilsenbeck SG, Chamness GC, Lewis MT, Dobrolecki LE, Jain D, Sahoo S, Osborne CK, Chang JC., Breast Cancer Res Treat, 1/1/2010
  • Veno-occlusive Disease after Treatment with Gemtuzumab Ozogamicin in a Patient with Acute Myeloid Leukemia and a History of Liver Transplantation for Familial Hemochro...  
    O�Boyle KP, Murigeppa A, Jain D et al, Med Oncol, 1/1/2003
  • Join now to see all

Abstracts/Posters

  • Compliance with oral antiestrogens utilizing a bubble pack
    Riley EC, Dragun A, McMasters K, Scoggins C, Quillo A, Rai S, Wu X, Jain D, ASCO Breast Symposium, 1/1/2014
  • A phase II trial of once-weekly hypo fractionated breast irradiation (WHBI): Interim analysis of cosmetic outcome and quality of life
    Dragun AE, Riley E, Quillo A, Barry P, Hunter A, Rajeur A, Roberts T, Rai S, Pan J, Jain D, Scoggins C, McMasters K, ASCO Breast Symposium, 1/1/2014
  • Demographic Trends in Clinical Trial Withdrawal Rate within the Bubble Study.
    Riley EC, Jain D, Kantardzic B, Wu X, Rai SN, 36th Annual San Antonio Breast Cancer Symposium, 1/1/2013
  • Join now to see all

Lectures

  • Cancer: Finding Positives 
    Markey Cancer Center, University of Kentucky - 1/1/2019
  • Breast Cancer Update: Moving Ahead With Caution 
    James G Brown Cancer Center, University of Louisville - 1/1/2017
  • Recent Data in Breast Cancer Therapeutics: Better Cocktail, Smart Mixing 
    James G Brown Cancer Center, University of Louisville - 1/1/2016
  • Join now to see all

Other

  • An Epidemiological and KAP (knowledge, attitude and practices) Study of Sexually Transmitted Diseases and HIV Among Rickshawpullers of Some Urban Slums of Delhi, Thesis 
    Jain D, University of Delhi, India
    1/1/1993

Committees

  • Member, ASCO Cinical Guidelines Implementation Network 2018 - Present

Professional Memberships

Other Languages

  • Hindi

Hospital Affiliations